Back to news

Fundsmith Emerging - Director/PDMR Shareholding

Back to news
RNS Number : 1479P
Fundsmith Emerging Equities Tst PLC
05 June 2020

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

David Potter

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-executive Director of the Issuer

 

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Fundsmith Emerging Equities Trust plc

b)

 

LEI

 

 

2138003EL6XV8JYU8V55

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary 1p shares

 

 

GB00BLSNND18

 

b)

 

Nature of the transaction

 

 

Acquisition of shares (re-investment of income in an ISA)

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

1,083.5 pence per share

 

27

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

 

27 Ordinary 1p shares

 

1,083.5 pence per share

e)

 

Date of the transaction

 

 

5 June 2020

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

Name of authorised official of issuer responsible for making notification:

Katherine Manson, for and on behalf of Frostrow Capital LLP

Company Secretary to FUNDSMITH EMERGING EQUITIES TRUST PLC


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHFLFIFRDIEIII